U.S. EPA Issues New Regulations, Reducing Residual Limit for Cyprodinil in Palm Oil to 0.02 ppm
According to an update from the U.S. Federal Register, on November 4, 2024, the U.S. Environmental Protection Agency (EPA) issued Regulation 2024-25564, which amends the residual limits of Mefenoxam in palm oil. This revision is based on a comprehensive risk assessment of metolaxyl toxicity, dietary exposure, and potential effects on infants and young children.
After an in-depth study and evaluation, EPA has concluded that the new residue limits are safe and has proposed the following revisions:
Product Name: Palm oil
New residue limit: 0.02 ppm (parts per million)
It is worth noting that Metalaxel has not been registered in the United States as of November 4, 2024. Therefore, the revised regulations will have an important impact on the residual limits of metalaxyl in palm oil.
According to the provisions, this regulation will come into force on 4 November 2024. Any person or organization that objects to this regulation or wishes to file a request for a hearing must submit the relevant documents to EPA by January 3, 2025. This deadline provides ample time for all stakeholders to express their views and concerns.
2026-07-30
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Slams Door on Chinese Food Exports: Inspection Refusals Trigger Automatic Detentions
-
Canada Issues Non-Compliance Notice to Dr. Reddy’s on Semaglutide Generic
-
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
WACKER’s 2025 Loss Reaches €805 Million as the PACE Cost-Cutting Plan Becomes the Key Variable for 2026
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
The FDA Officially Blesses AI for Liver Drug Development
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
South Korea’s Largest Petrochemical Hub Moves to Cut Cracker Capacity by 40%
-
FDA Reopens BHA Review—Why One Preservative Is Becoming a Global Wake-Up Call for Food Additives
Recommend Reading
-
China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle
-
U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
Bayer and Syngenta Score Consecutive Regulatory and Legal Wins in the U.S.
-
South Korea Expands Mandatory GMO Labeling to Highly Processed Foods
-
Cost-side Speculative Sentiment Rises, PP Strongly Rebounds in Early July
-
Remote Raw Material Boost, PC Prices Recover After Falling in the First Half of July in China
-
Restocking Boosts Short-term Consumption, ABS Stabilizes and Rebounds in the First Half of July in China
-
Crude Oil Boosts Butadiene Market Uptrend
-
Stable Shipping, Stable Activated Carbon Prices in China